Mild moxibustion at tianshu (ST 25) decreases expression of prokineticin-1 and prokineticin receptor-1 in colon tissue of rats with chronic visceral hyperalgesia

Neural Regeneration Research

Volumn 6, Issue 33, 2011, Pages 2600-2604

  Wu, Luyi ^a   Bao, Chunhui ^a   Ge, Linbao ^a   Zhou, Cili ^a   Liu, Huirong ^a   Qi, Li ^a   Yi, Tao ^a   Wu, Huangan ^a   Wang, Xiaomei ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chronic visceral hyperalgesia; Irritable bowel syndrome; Mild moxibustion; Neural regeneration; Prokineti cins

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INTESTINE DISTENSION; MALE; MOXIBUSTION; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; TREATMENT OUTCOME; VISCERAL HYPERALGESIA;

EID: 82455162676     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2011.33.007     Document Type: Article

References (35)

1. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology. 1987; 92(6):1885-1893.
2. Chey WY, Jin HO, Lee MH, et al. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol. 2001;96(5):1499-1506.
3. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480-1491.
4. Grundmann O, Yoon SL, Moshiree B. Current developments for the diagnosis and treatment of irritable bowel syndrome. Curr Pharm Des. 2010;16(33):3638-3645.
5. Spanier JA, Howden CW, Jones MP. A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med. 2003;163(3): 265-274.
6. Giese LA. A study of alternative health care use for gastrointestinal disorders. Gastroenterol Nurs. 2000;23(1):19-27.
7. Duan CQ, Li AP. Clinical research of warmed needling with moxibustion on treatment of patients with irritable bowel syndrome. Zhongguo Zhenjiu. 2001;21(4):1-9.
8. Liu HR, Yang Y, Wu HG. Clinical study on acupuncture in treating diarrhea-predominant irritable bowel syndrome. J Acupunct Tuina Sci. 2008;6(6):360-362.
9. Wang JH, Wu HG, Chen HP. Clinical research of 28 cases of patients with irritable bowel syndrome treated by herb-partition moxibustion. Shanghai Zhenjiu Zazhi. 1995;15(1):6-7.
10. Wu HG, Wang JH, Chen HP, et al. Exploration of efficacy and immunological mechanism for IBS treated by herb-partition moxibustion. Zhongguo Zhenjiu. 1996;16(2):43-45.
11. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology. 2000;119(5): 1276-1285.
12. Anastasi JK, McMahon DJ, Kim GH. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion. Gastroenterol Nurs. 2009;32(4): 243-255.
13. Zhang LS, Shi Y. ST25 in treatment of patients with intestinal tract diseases by acupuncture and moxibustion therapies. Jiangxi Zhongyi Zazhi. 2004;35(12):53-56.
14. Liu HR, Qi L, Wang XL, et al. Electroacupuncture at Tianshu (ST 25) for diarrhea-predominant irritable bowel syndrome using positron emission tomography. Neural Regen Res. 2010;5(16): 1220-1225.
15. Wang XM, Liu HR, Ding GH, et al. Effects of electroacupuncture on c-Fos expression in the spinal cord and brain of rats with chronic visceral hypersensitivity. Neural Regen Res. 2009; 4(5):339-343.
16. Wu HG, Jiang B, Zhou EH et al. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion. Dig Dis Sci. 2008;53(6):1644-1651.
17. Negri L, Lattanzi R, Giannini E, et al. Bv8/Prokineticin proteins and their receptors. Life Sci. 2007;81(14):1103-1116.
18. Li M, Bullock CM, Knauer DJ, et al. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol. 2001;59(4): 692-698.
19. Maldonado-Pérez D, Evans J, Denison F, et al. Potential roles of the prokineticins in reproduction. Trends Endocrinol Metab. 2007; 18(2):66-72.
20. Negri L, Lattanzi R, Giannini E, et al. Modulators of pain: Bv8 and Prokineticins. Curr Neuropharmacol. 2006;4(3):207-215.
21. Negri L, Lattanzi R, Giannini E, et al. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J Neurosci. 2006; 26(25):6716-6727.
22. Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109(1):40-52.
23. Zhou EH, Liu HR, Wu HG, et al. Herb-partition moxibustion relieves chronic visceral hyperalgesia and 5-HT concentration in colon mucosa of rats. Neurol Res. 2009;31(7):734-737.
24. Zhou EH, Liu HR, Wu HG, et al. Suspended moxibustion relieves chronic visceral hyperalgesia via serotonin pathway in the colon. Neuroscience Letters. 2009;451(2):144-147.
25. Wu HG, Liu HR, Zhang ZA, et al. Electro-acupuncture relieves visceral sensitivity and decreases hypothalamic corticotropin-releasing hormone levels in a rat model of irritable bowel syndrome. Neurosci Lett. 2009;465(3):235-237.
26. Cui KM, Li WM, Gao X et al. Electro-acupuncture relieves chronic visceral hyperalgesia in rats. Neurosci Lett. 2005;376(1):20-23.
27. Tian SL, Wang XY, Ding GH. Repeated electro-acupuncture attenuates chronic visceral hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat irritable bowelsyndrome model. Life Sci. 2008; 83(9-10):356-363.
28. Liu HR, Wang XM, Zhou EH, et al. Acupuncture at both ST25 and ST37 improves the pain threshold of chronic visceral hypersensitivity rats. Neurochem Res. 2009;34(11):1914-1918.
29. Mollay C, Wechselberger C, Mignogna G, et al. Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur J Pharmacol. 1999;374(2): 189-196.
30. de Novellis V, Negri L, Lattanzi R, et al. The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflexes in the rat. Eur J Neurosci. 2007;26(11): 3068-3078.
31. Negri L, Lattanzi R, Giannini E, et al. Bv8/Prokineticin and their receptors: a new pronociceptive system. Int Rev Neurobiol. 2009;85:145-157.
32. Negri L, Lattanzi R, Giannini E, et al. Nociceptive sensitization by the secretory protein Bv8. Br J Pharmacol. 2002;137(8): 1147-1154.
33. Kimball ES, Prouty SP, Pavlick KP, et al. Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis. Neurogastroenterol Motil. 2007;19(5):390-400.
34. Giannini E, Lattanzi R, Nicotra A, et al. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci U S A. 2009; 106(34):14646-14651.
35. Hoogerwerf WA. Prokineticin1 inhibits spontaneous giantcontractions in the murine proximal colon through nitricoxide release. Neurogastroenterol Motil. 2006;18(6):455-463.